BOLALARDAGI KICHIK YURAK ANOMALIYALARINING ZAMONAVIY KO‘RINISHI

TO'LIQ MATN:

Abstrakt

Sharhda bolalarda yurak-qon tomir tizimining tug'ma yoki erta orttirilgan morfologik xususiyatlarini o'z ichiga olgan, aniq gemodinamik buzilishlarga olib kelmaydigan kichik yurak anomaliyalari (KYuA) haqidagi zamonaviy ma'lumotlar keltirilgan. KYuA ning asosiy turlari (mitral klapan prolapsi, ochiq oval teshik, qo'shimcha xordalar va boshqalar) ko'rib chiqiladi, aniqlash chastotasi va ularning shakllanishiga ta'sir qiluvchi omillar, shu jumladan irsiy moyillik va biriktiruvchi to'qima displaziyasi haqida ma'lumotlar keltirilgan. Klinik ko'rinishlar tasvirlangan - asimptomatik kechishidan yengil kardialgiya va avtonom kasalliklarga qadar. Asosiy e'tibor diagnostika imkoniyatlariga, birinchi navbatda exokardiyografiyaga, shuningdek, elektrokardiografiya va boshqa tadqiqot usullarining rolini baholashga qaratilgan. KYuA bilan kasallangan bolalarni boshqarish va dinamik kuzatishga individual yondashuv zarurligi ta'kidlanadi: ko'pgina holatlar faol davolanishni talab qilmaydi, ammo bir nechta kombinatsiyalangan anomaliyalar, klapanlarning kuchli regurgitatsiyasi yoki ritm buzilishlarini dori-darmonlar bilan tuzatish va kuchli nazorat qilishni talab qilishi mumkin. Xulosa qilib aytganda, profilaktika va sog'lom turmush tarzi masalalari, shuningdek, molekulyar genetik asoslarni o'rganish va shaxsiylashtirilgan boshqaruv tavsiyalarini ishlab chiqish istiqbollari muhokama qilinadi.

Mualliflar haqida

Adabiyotlar ro'yxati

Akhmedova Д. ., & Sotvoldieva М. . (2024). CONGENITAL HEART DEFECTS IN CHILDREN: PREVALENCE, DEVELOPMENT FACTORS, PRINCIPLES OF PREVENTION AND SCREENING. International Journal of Scientific Pediatrics, 3(1), 463–474. https://doi.org/10.56121/2181-2926-2024-3-1-463-474

Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341(1):1–7.

Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child Fetal Neonatal Ed. 1999;80(1):F49–F53.

Perloff JK. Clinical Recognition of Congenital Heart Disease. 6th ed. Philadelphia: Elsevier; 2012.

Corone S, Iliou MC, Manderscheid JC, Lim P, Sebaoun A, Raczka F, et al. Outcome of children with minor congenital heart disease. Cardiol Young. 2007;17(2):221–232.

Gatzoulis MA, Webb GD, Daubeney PEF. Diagnosis and Management of Adult Congenital Heart Disease. 3rd ed. Philadelphia: Elsevier; 2018.

Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352(6333):337–339.

Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900.

Roguin N, Du ZD, Barak M, Valsangiacomo Buechel ER, Embon OM. Minor congenital heart anomalies: echocardiographic evaluation of prevalence in schoolchildren. Int J Cardiol. 2005;98(3):441–444.

Delling FN, Vasan RS. Epidemiology and pathophysiology of mitral valve prolapse. New insights into disease progression, genetics, and molecular basis. Circulation. 2014;129(21):2158–2170.

Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life. An autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17–20.

Robinson PN, Booms P. The molecular pathogenesis of the Marfan syndrome. Cell Mol Life Sci. 2001;58(12-13):1698–1707.

Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge. Circulation. 2007;115(23):2995–3014.

Norrish G, Field E, Kaski JP. The role of genetics in cardiomyopathy diagnosis in children. Curr Opin Pediatr. 2019;31(5):587–593.

Massin MM, Bourguignont A, Coremans C, Comté L, Lepage P, Gérard P, et al. Chest pain in pediatric patients presenting to an emergency department or to a cardiac clinic. Clin Pediatr (Phila). 2004;43(3):231–238.

Silka MJ, Bar-Cohen Y. When to evaluate and treat palpitations in children. Pediatr Clin North Am. 2004;51(5):1521–1538.

Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476–485.

Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, et al. Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr. 2006;19(12):1413–1430.

Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318(18):1148–1152.

Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis. Guidelines from the American Heart Association. Circulation. 2007;116(15):1736–1754.

Sani MU, Mukhtar-Yola M, Karaye KM. Spectrum of congenital heart disease in a tropical environment: an echocardiographic study. J Natl Med Assoc. 2007;99(6):665–669.

Qanday qilib iqtibos keltirish kerak

Achilova Ф. (2025). BOLALARDAGI KICHIK YURAK ANOMALIYALARINING ZAMONAVIY KO‘RINISHI. Xalqaro Ilmiy Pediatriya Jurnali, 4(2), 947–953. https://doi.org/10.56121/2181-2926-2025-4-2-947-953
Ko'rishlar soni: 0